An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1543673.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ten patients with dry non-inflammatory tinea capitis were evaluated in a pilot study which ran from September 1989 to February 1990. Each patient was given oral terbinafine for 6 weeks; each was followed up 2 weeks later. Eight (80%) were completely cured, one (10%) was mycologically cured and showed minimal signs and symptoms, and another (10%) showed improvement (negative mycology, but persistent clinical signs and symptoms). No topical or systemic side-effects were noted. Terbinafine appears to be an effective and safe antifungal agent in the treatment of non-inflammatory tinea capitis.
Medical subject headings
- Antifungal Agents
- Naphthalenes
- Tinea Capitis